In Brief Andrew Baschnagel wins UW Carbone Cancer Center award for lung cancer study July 28, 2017Vol.43 No.30
ODAC unanimously recommends approval for CAR T-cell therapy for relapsed and refractory B-cell ALL in kids and young adults July 14, 2017Vol.43 No.28By Claire Dietz and Paul Goldberg
Removed from U.S. market in 2011, Pfizer’s Mylotarg slated to return following results of a French study that tested a new regimen July 14, 2017Vol.43 No.28By Paul Goldberg
FY18 health budget battle begins: House appropriators slate $1.1 billion increase for NIH while defunding ACA, Title X July 14, 2017Vol.43 No.28By Matthew Bin Han Ong
In Brief Steven Piantadosi steps down at Cedars-Sinai to focus on clinical trial design July 14, 2017Vol.43 No.28
In Brief Interdisciplinary program at NYU Langone targets pancreatic cancer July 14, 2017Vol.43 No.28
Drugs & Targets FDA converts accelerated approval of Amgen’s Blincyto to full approval in ALL July 14, 2017Vol.43 No.28
